RU2022103366A3 - - Google Patents

Download PDF

Info

Publication number
RU2022103366A3
RU2022103366A3 RU2022103366A RU2022103366A RU2022103366A3 RU 2022103366 A3 RU2022103366 A3 RU 2022103366A3 RU 2022103366 A RU2022103366 A RU 2022103366A RU 2022103366 A RU2022103366 A RU 2022103366A RU 2022103366 A3 RU2022103366 A3 RU 2022103366A3
Authority
RU
Russia
Application number
RU2022103366A
Other languages
Russian (ru)
Other versions
RU2022103366A (ru
Filing date
Publication date
Application filed filed Critical
Publication of RU2022103366A publication Critical patent/RU2022103366A/ru
Publication of RU2022103366A3 publication Critical patent/RU2022103366A3/ru

Links

RU2022103366A 2016-06-24 2017-06-26 Составы, устройства и способы для лечения алкогольной зависимости RU2022103366A (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662354465P 2016-06-24 2016-06-24
US62/354,465 2016-06-24
US201662419736P 2016-11-09 2016-11-09
US62/419,736 2016-11-09

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2019101810A Division RU2767062C2 (ru) 2016-06-24 2017-06-26 Составы, устройства и способы для лечения алкогольной зависимости

Publications (2)

Publication Number Publication Date
RU2022103366A RU2022103366A (ru) 2022-03-01
RU2022103366A3 true RU2022103366A3 (cg-RX-API-DMAC7.html) 2025-06-27

Family

ID=60784803

Family Applications (2)

Application Number Title Priority Date Filing Date
RU2022103366A RU2022103366A (ru) 2016-06-24 2017-06-26 Составы, устройства и способы для лечения алкогольной зависимости
RU2019101810A RU2767062C2 (ru) 2016-06-24 2017-06-26 Составы, устройства и способы для лечения алкогольной зависимости

Family Applications After (1)

Application Number Title Priority Date Filing Date
RU2019101810A RU2767062C2 (ru) 2016-06-24 2017-06-26 Составы, устройства и способы для лечения алкогольной зависимости

Country Status (13)

Country Link
US (1) US20190209464A1 (cg-RX-API-DMAC7.html)
EP (1) EP3474842A4 (cg-RX-API-DMAC7.html)
JP (2) JP2019520361A (cg-RX-API-DMAC7.html)
KR (2) KR102634829B1 (cg-RX-API-DMAC7.html)
CN (1) CN109789122A (cg-RX-API-DMAC7.html)
AU (2) AU2017281941A1 (cg-RX-API-DMAC7.html)
CA (1) CA3028731A1 (cg-RX-API-DMAC7.html)
MX (2) MX2018015985A (cg-RX-API-DMAC7.html)
NZ (1) NZ750067A (cg-RX-API-DMAC7.html)
PH (1) PH12018502738A1 (cg-RX-API-DMAC7.html)
RU (2) RU2022103366A (cg-RX-API-DMAC7.html)
SG (2) SG10202013034QA (cg-RX-API-DMAC7.html)
WO (1) WO2017223566A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ750067A (en) * 2016-06-24 2025-11-28 Aegis Therapeutics Llc Compositions, devices, and methods for the treatment of alcohol use disorder
US11069446B1 (en) * 2016-09-28 2021-07-20 Cerner Innovation, Inc. Predicting addiction relapse and decision support tool
CA3043028A1 (en) * 2016-11-09 2018-05-17 Opiant Pharmaceuticals, Inc. Compositions, devices, and methods for the treatment of opioid-receptor-mediated conditions
WO2018093666A1 (en) * 2016-11-18 2018-05-24 Opiant Pharmaceuticals, Inc. Compositions and methods for the treatment of opioid overdose
JP6941224B2 (ja) 2018-02-06 2021-09-29 イージス セラピューティクス,エルエルシー 疾患の処置のための鼻腔内エピネフリン製剤及び方法
US20210220346A1 (en) * 2018-05-17 2021-07-22 Aegis Therapeutics Llc Formulations and methods for the prevention of opioid overdose
WO2020132263A1 (en) * 2018-12-20 2020-06-25 Aegis Therapeutics, Inc. Compositions, devices, and methods for the treatment of overdose and reward-based disorders
CA3134943A1 (en) 2019-03-26 2020-10-01 Pocket Naloxone Corp. Devices and methods for delivering pharmaceutical compositions
JP7900916B2 (ja) * 2019-05-16 2026-08-05 株式会社新日本科学 経鼻投与用の粉末製剤及びその製造方法
US10653690B1 (en) * 2019-07-09 2020-05-19 Orexo Ab Pharmaceutical composition for nasal delivery
US10729687B1 (en) 2019-07-09 2020-08-04 Orexo Ab Pharmaceutical composition for nasal delivery
CA3166250A1 (en) 2020-02-05 2021-08-12 Gregory G. Plucinski Drug products for intranasal administration and uses thereof
US11278709B1 (en) 2021-03-12 2022-03-22 Pocket Naloxone Corp. Drug delivery device and methods for using same
CA3227828A1 (en) 2021-08-04 2023-02-09 Indivior Inc. Compositions and methods for the treatment of opioid overdose
EP4469027A4 (en) * 2022-01-26 2025-11-12 Tulex Pharmaceuticals Inc NEW COMPOSITIONS

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4882335A (en) * 1988-06-13 1989-11-21 Alko Limited Method for treating alcohol-drinking response
US5069895A (en) * 1989-11-09 1991-12-03 Diamond Ivan F Methods for the treatment of alcohol intoxication and dependence
EP0444778A1 (en) * 1990-02-14 1991-09-04 Alcon Laboratories, Inc. Use of alkyl saccharides to enhance the penetration of drugs
EP1423116A1 (en) * 2001-08-14 2004-06-02 Biotie Therapies Corp. Method of treating alcoholism or alcohol abuse
US8268791B2 (en) * 2004-08-25 2012-09-18 Aegis Therapeutics, Llc. Alkylglycoside compositions for drug administration
US9895444B2 (en) * 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
US20070212307A1 (en) * 2006-02-10 2007-09-13 Daniel Wermeling Pharmaceutical Compositions Comprising an Opioid Receptor Antagonist and Methods of Using Same
WO2008095086A2 (en) * 2007-01-31 2008-08-07 University Of Virginia Patent Foundation Topiramate plus naltrexone for the treatment of addictive disorders
JP2010537990A (ja) * 2007-08-27 2010-12-09 ユニバーシティ オブ バージニア パテント ファウンデーション アルコール中毒および薬物嗜癖の処置のための医薬の組み合わせ
WO2009128474A1 (ja) * 2008-04-16 2009-10-22 財団法人化学及血清療法研究所 トロンビン固定化生体吸収性シート製剤の製造方法
ES2686299T3 (es) * 2010-10-29 2018-10-17 Troikaa Pharmaceuticals Ltd Composiciones nasales de vitamina B12
HRP20180233T1 (hr) * 2011-05-13 2018-06-01 Euro-Celtique S.A. Intranazalni farmaceutski oblici doziranja koji sadrže nalokson
US10485798B2 (en) * 2012-08-22 2019-11-26 Aptapharma Inc. Methylnaltrexone nasal formulations, methods of making, and use thereof
US20140171458A1 (en) * 2012-12-13 2014-06-19 3B Pharmaceuticals, Inc. Intranasal naltrexone
DE202013105715U1 (de) * 2013-08-22 2014-02-19 Sipnose Ltd. Vorrichtung zur Abgabe einer vorbestimmten Menge einer Substanz an eine natürliche Öffnung des Körpers
WO2015095389A1 (en) 2013-12-18 2015-06-25 Aegis Therapeutics, Llc Compositions for drug administration
US9480644B2 (en) * 2014-03-14 2016-11-01 Opiant Pharmaceuticals, Inc. Nasal drug products and methods of their use
NZ750067A (en) 2016-06-24 2025-11-28 Aegis Therapeutics Llc Compositions, devices, and methods for the treatment of alcohol use disorder

Similar Documents

Publication Publication Date Title
CN309041008S (zh) 橱柜拉篮(300)
CN308863121S (zh) 书本(化工操作技术)
CN308754146S (zh) 眼镜夹片(a)
CN308403370S (zh) 鞋底(23124)
CN308403607S (zh) 面料(ly-20252)
CN308407670S (zh) 皮草外套(23203-3)
CN308403316S (zh) 鞋底(hy7283)
CN308690156S (zh) 带灯充电宝(p10)
CN308553965S (zh) 玩具(发射器陀螺)
CN308428297S (zh) 米桶
CN308408432S (zh) 餐桌(Jh04)
CN308407812S (zh) 鞋底(160)
CN308407025S (zh) 草坪灯(精灵b款)
CN308403999S (zh) 转角置物架(吸盘波纹)
CN308405665S (zh) 插头(Plug03)
CN308407808S (zh) 鞋面(鳄鱼纹元素)
CN308598653S (zh) 赛车前翼(fsae)
CN308406064S (zh) 电路板(触控变色笔)
CN308403083S (zh) 内裤(水滴丰胯裤)
CN308403984S (zh) 置物架(花影)
CN308403144S (zh) 衣服(线条纹)
CN308403711S (zh) 沙发(9113)
CN308407764S (zh) 拖鞋
CN308403985S (zh) 安全柜
CN308407147S (zh) 筒灯